Citable filing context

ECL filing events and research context

Server-rendered

ECL's research view summarizes recent SEC filing context, starting with mda_quarterly from May 7, 2026.

ECL filing events and research context
FiledItemContext
May 7, 2026mda_quarterlyEcolab’s first-quarter 2026 reported net sales increased 10% to $4,066.1 million, with organic sales up 4%, driven by pricing gains of 3% and volume growth of 1%. Adjusted diluted EPS rose 13% to $1.70. Segment performance was led by Global Life Sciences, which grew 11% organically, and Global Pest Elimination, up 7%. Global Water organic sales grew 2%, led by a 25% surge in High-Tech (microelectronics and data centers), while total segment sales benefited from the Ovivo Electronics acquisition. Global Institutional & Specialty organic sales rose 4%. Adjusted gross margin contracted to 43.8% due to acquisitions, while underlying margins remained stable as value pricing offset rising commodity costs. To counter Middle East war-related energy and logistics inflation, Ecolab is implementing a Q2 energy surcharge. The "One Ecolab" restructuring program incurred $57.7 million in quarterly charges and is projected to deliver $325 million in annualized savings by 2027. Net debt to EBITDA stood at 2.1x, with interest expense rising to $72.7 million following the Ovivo transaction. Notably, Ecolab secured a $4.75 billion credit facility in April 2026 to fund its pending acquisition of CoolIT Systems.
Feb 23, 2026businessEcolab is a global leader in water, hygiene, and infection prevention solutions, serving the food, healthcare, high-tech, life sciences, hospitality, and industrial markets across more than 170 countries. The company operates through four reportable segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. Strategic growth is currently driven by the $1.6 billion acquisition of Ovivo Electronics, which adds ultrapure water technologies for semiconductor manufacturing to the Global Water portfolio. To optimize its cost structure and expand margins, the company is executing the "One Ecolab" initiative, a restructuring program designed to leverage digital technologies and global centers of excellence. Financial performance is characterized by strong organic growth in the Pest Elimination and Life Sciences segments, supported by value pricing and productivity improvements. However, the company faces material risks from significant foreign currency exposure, as approximately half of its sales are generated outside the United States. Additionally, Ecolab manages geopolitical risks related to its limited operations in Russia and Ukraine, as well as economic volatility in highly inflationary markets, specifically Argentina, Turkey, and Egypt. The company recently refined its portfolio through the divestiture of its global surgical solutions business.
Feb 23, 2026mdaEcolab achieved record 2025 performance with reported sales of $16.1 billion and 3% organic growth. Growth was led by Global Pest Elimination (+6% organic) and Global Life Sciences (+5% organic), while Global Water (+2% organic) saw strong demand from data centers and microelectronics offsetting softness in basic industries. A pivotal strategic move was the $1.6 billion acquisition of Ovivo Electronics to enter the semiconductor ultrapure water market. To enhance margins, the "One Ecolab" restructuring initiative targets $325 million in annualized savings by 2027 through digital realignment and global centers of excellence. Financially, the company generated $3.0 billion in operating cash flow and maintains $8.2 billion in total debt with a net debt to EBITDA ratio of 2.0. Key risks include stringent chemical regulations under TSCA and REACH, the legal and operational complexities of integrating artificial intelligence, and geopolitical instability in Russia and Ukraine. Environmental targets include achieving net zero GHG emissions by 2050 and reducing net water withdrawals by 40% per unit of production. The company continues its long-term shareholder return strategy, marking its 34th consecutive annual dividend increase in 2025.

Source: SEC EDGAR filing text and events; period May 7, 2026; filed May 7, 2026.

Continue research

Keep researching ECL

Follow same-sector companies and source explainers connected to the research view.

Related tickers

NEM
Newmont
$105.66B
Materials
Open company page →
FCX
Freeport-McMoRan
$91.86B
Materials
Open company page →
SHW
Sherwin-Williams
$73.88B
Materials
Open company page →
CRH
CRH plc
$67.90B
Materials
Open company page →
APD
Air Products
$61.64B
Materials
Open company page →
NUE
Nucor
$57.70B
Materials
Open company page →

Related explainers

Understanding 8-K filings

A factual guide to SEC Form 8-K current reports and the material company events they can disclose between quarterly filings.

Read explainer →
Reading a 10-Q

A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.

Read explainer →
S-1 and the IPO prospectus

A factual guide to Form S-1 registration statements and the disclosures companies provide before a public offering.

Read explainer →
Reading an SEC 10-K

A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.

Read explainer →